Mice (BDF(1)) inoculated with L1210 leukemia survive for a statistically significantly longer span when four courses of arabinosyl cytosine are administered at 4-day intervals-not in courses consisting of eight equal doses at 3-hour intervals, but in sinusoidally increasing and decreasing 24-hour courses, the largest amount being given at previously mapped circadian and circannual times of peak host resistance to the drug. This finding relates to the many therapeutic situations involving rhythmic, and thus predictable, cycles in the host's tolerance of undesired effects from the agent used.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1126/science.177.4043.80 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Green Light-Triggerable Chemo-Photothermal Activity of Cytarabine-Loaded Polymer Carbon Dots: Mechanism and Preliminary In Vitro Evaluation.
ACS Appl Mater Interfaces
February 2023
CIB-Interuniversity Consortium for Biotechnologies, University of Catania, Via Flavia, 23/1, 34148Trieste, Italy.
Article Synopsis
- Carbon-based nanostructures, known for low toxicity and excellent properties, are being developed as multifunctional treatments for cancer through a chemo-photothermal approach.
- The study introduces a novel type of photoresponsive carbon-based polymer dots (CPDs-PNM) made from poly(-isopropylacrylamide) using a simple thermal process, showing high photothermal efficiency and good drug loading capabilities.
- CPDs-PNM were shown to safely deliver the chemotherapy drug AraC and, when activated by green light, enhanced its toxicity against neuroblastoma cells, demonstrating a synergistic effect for cancer treatment.
TGFβ1 synergizes with FLT3 ligand to induce chemoresistant quiescence in acute lymphoblastic leukemia with MLL gene rearrangements.
Leuk Res
October 2017
Department of Pediatrics, Graduate School of Medicine, University of Yamanashi, Yamanashi, Japan. Electronic address:
Fms-like tyrosine kinase 3 (FLT3) is highly expressed in mixed-lineage leukemia (MLL) gene-rearranged acute lymphoblastic leukemia (MLL+ALL) with a dismal prognosis. We previously reported that FLT3 ligand (FL) stimulation induced cell cycle arrest in MLL+ALL cells leading to resistance against anti-leukemic agents. Given that FL stimulation enhanced transforming growth factor (TGF)β1 mRNA levels in MLL+ALL cells, we extensively examined the effect of TGFβ1 on the cell cycle progression and chemosensitivity in MLL+ALL cells, and found that TGFβ1 stimulation induced MLL+ALL cells into cell cycle arrest resistant to arabinosyl cytosine; its effect was markedly enhanced in synergy with FL.
View Article and Find Full Text PDFTDP1 is Critical for the Repair of DNA Breaks Induced by Sapacitabine, a Nucleoside also Targeting ATM- and BRCA-Deficient Tumors.
Mol Cancer Ther
November 2017
Developmental Therapeutics Branch and Laboratory of Molecular Pharmacology, Center for Cancer Research, NCI, NIH, Bethesda, Maryland.
2'--cyano-2'-deoxy-1-β-d-arabino-pentofuranosylcytosine (CNDAC) is the active metabolite of the anticancer drug, sapacitabine. CNDAC is incorporated into the genome during DNA replication and subsequently undergoes β-elimination that generates single-strand breaks with abnormal 3'-ends. Because tyrosyl-DNA phosphodiesterase 1 (TDP1) selectively hydrolyzes nonphosphorylated 3'-blocking ends, we tested its role in the repair of CNDAC-induced DNA damage.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!